News Nuformix plc

Equities

Market Closed - London S.E. Other stock markets 16:35:18 02/05/2024 BST			5-day change	1st Jan Change
0.185 ^GBX	0.00%		-9.76%	-43.08%

03-01	Nuformix announces subscription to raise GBP150,000	AN
01-15	Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	CI

Nuformix announces subscription to raise GBP150,000	03-01	AN
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	01-15	CI
Nuformix narrows annual loss as develops drug assets	01-03	AN
Earnings Flash (NFX.L) NUFORMIX Reports FY23 Loss GBX-0.12	01-03	MT
Nuformix plc Reports Earnings Results for the Half Year Ended September 30, 2023	01-03	CI
Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002	23/10/23	AN
Nuformix Receives Japanese Patent for Pulmonary Fibrosis Treatment; Shares Surge	23/10/23	MT
Nuformix plc Announces Notice of Allowance of NXP002 Patent in Japan	23/10/23	CI
Nuformix to fund its unlicensed programs with NXP001 windfall	05/10/23	AQ
Nuformix Updates Oxilio Agreement for NXP001	18/09/23	MT
Nuformix to receive milestone payments from Oxilio pact	18/09/23	AN
Nuformix plc Receives New NXP001 Development Milestone Payments in Updated Oxilio Agreement	18/09/23	CI
Nuformix loss narrows; near-term goal to focus on NXP002 asset	22/05/23	AN
Earnings Flash (NFX.L) NUFORMIX Posts FY23 EPS GBX0.11	22/05/23	MT
Earnings Flash (NFX.L) NUFORMIX Posts Fiscal H1 EPS GBX0.11	22/05/23	MT
Nuformix plc Reports Earnings Results for the Full Year Ended March 31, 2023	22/05/23	CI
Nuformix says NXP002 shows anti-inflammatory effect	18/05/23	AN
Nuformix to Launch Partnering Process for Inhaled Lung Disease Drug	18/05/23	MT
Nuformix plc Announces Update Regarding the NXP002 Programme	18/05/23	CI
FTSE 100 Inches Up as Market Awaits Key Inflation, Earnings Figures	17/04/23	DJ

No results for this search